Stanford professor Russ Altman emphasizes that AI is opening new opportunities to understand how medicines interact with specific proteins, and build more highly customized therapies. He points to DeepMind’s AlphaFold 2 deep learning system as a particularly powerful new tool for re-envisioning how drugs are discovered and designed.
Video clips from: Principled Engineering: AI and Drug Development [Entire Talk]
Related Articles
Debbie Sterling (GoldieBlox) – Disrupting the Pink Aisle [ETL Looks Back]
Debbie Sterling,
GoldieBlox
Debbie Sterling's journey highlights the importance of supporting young girls in STEM fields.
Investing on the Cutting Edge: Innovation that Pushes Boundaries
Josh Wolfe emphasizes that successful entrepreneurship today hinges on leveraging genuine scientific breakthroughs and wise capital management, especially during challenging economic times.
Maria Barrera (Clayful) – Mental Health for Entrepreneurs [ETL Looks Back]
Maria Barrera,
Clayful
